Ascendis Pharma
ASND
ASND
36 hedge funds and large institutions have $146M invested in Ascendis Pharma in 2015 Q1 according to their latest regulatory filings, with 36 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
36
Holders Change
+36
Holders Change %
–
% of All Funds
0.96%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
36
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SCM
26
Sterling Capital Management
Charlotte,
North Carolina
| $337K | +$337K | +19,452 | New |
|
|
PI
27
Putnam Investments
Boston,
Massachusetts
| $326K | +$326K | +18,809 | New |
|
28
Bank of America
Charlotte,
North Carolina
| $293K | +$293K | +16,892 | New |
|
|
UOC
29
UBS O'Connor
Chicago,
Illinois
| $177K | +$177K | +10,228 | New |
|
|
PA
30
Perceptive Advisors
New York
| $174K | +$174K | +10,000 | New |
|
|
BIM
31
BlackRock Investment Management
Wilmington,
Delaware
| $153K | +$153K | +8,800 | New |
|
32
Morgan Stanley
New York
| $91K | +$91K | +5,250 | New |
|
33
Wells Fargo
San Francisco,
California
| $45K | +$45K | +2,575 | New |
|
|
TRCT
34
Tower Research Capital (TRC)
New York
| $23K | +$23K | +1,323 | New |
|
35
UBS Group
Zurich,
Switzerland
| $15K | +$15K | +865 | New |
|
36
Citigroup
New York
| $1K | +$1K | +80 | New |
|